// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Transplantation of DCD Livers vs. NDD and LDLT: Is There a Difference in Post-Transplant Kidney Dysfunction?

D. Kollmann - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Nephrology

N/A

N/A

Transplantation of Very Small Pediatric En Bloc Renal Allografts from Donors Less Than 8 Months of Age Have Similar Outcomes to Donors More Than 8 Months

S. Aquil - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Nephrology

N/A

N/A

Urine AngiotensinII Signature Proteins as Biomarkers of Fibrosis in Kidney Transplant Recipients

Z. Mohammed-Ali - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Nephrology

N/A

Angiotensin II

Use of Hepatitis-C Treatments after Kidney Transplantation: Impact of the Direct-Acting Antiviral Era

K. Lentine - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

Sofosbuvir

Using the Explore Transplant Ontario Program to Increase Transplant Knowledge and Readiness among Patients on Maintenance Dialysis

D. Belenko - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Nephrology

N/A

N/A

Val-Ganciclovir Prophylaxis Delays Onset of EBV Viremia in the First Year Post-Solid Organ Transplantation in High-Risk Patients

S. Albatati - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Ganciclovir

Validating Molecular Microscope Readings and Estimating Agreement with Histology

P. Halloran - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Other

N/A

N/A

Validation of Edmonton Symptom Assessment Survey in Kidney Transplant Recipients (KTR)

M. Pokarowski - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Validation of the PROMIS-57 and PROMIS-29 Questionnaires in Kidney Transplant Recipients

E. Tang - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Weight Changes before and after Kidney Donation

A. Bugeja - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

What's Normal? An Evaluation of Pediatric T Cell Markers in Healthy Controls

M. Sosniuk - American Transplant Congress (ATC) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Sex Differences in Health Services Use and Medication Prescription in Older Adults with Asthma in Ontario, Canada

N. Gray - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

The Long-Term Projection of Health and Economic Burden of Sub-Optimal Asthma Control in Canada

Z. Zafari - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Hospital Surgical Lung Biopsy Volume and Post-Operative Mortality in Interstitial Lung Disease

J. Fisher - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Risk Assessment in Scleroderma Patients with Newly Diagnosed Pulmonary Arterial Hypertension: Application of the ESC ERS Risk Prediction Model

V. Mercurio - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Smoking Gene Expression Signature of Mice and Human Lung Tissues and Its Overlap with COPD Signature

M. Obeidat - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Synergistic Effect of β2 Agonist, Rho Kinase Inhibitor, and Force Oscillation on Relaxation of Contracted Airway Smooth Muscle

L. Wang - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Acetylcholine

Shortening Velocity, Power Output, and Myosin Phosphorylation in Fully and Partially Activated Airway Smooth Muscle

L. Luo - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Repeated Bronchoconstrictions Do Not Alter Respiratory Mechanics in Mice

S. Mailhot-Larouche - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Characterizing Parenchymal Destruction in Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) Using Micro-Computed Tomography (MicroCT) Imaging and Stereology

A. Hsieh - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved